Related Experiment Videos
Pleural Alveolar Rhabdomyosarcoma.
Clinical Laboratory
|October 17, 2017
Summary
A rare pediatric pleural alveolar rhabdomyosarcoma (ARMS) case presented with dyspnea. This aggressive soft tissue cancer showed a poor prognosis, resisting standard chemotherapy treatments.
Area of Science:
- Pediatric Oncology
- Sarcoma Research
- Molecular Pathology
Background:
- Alveolar rhabdomyosarcoma (ARMS) is a rare and aggressive pediatric soft tissue malignancy.
- Pleural ARMS is an exceptionally rare presentation of this disease.
Observation:
- A pediatric patient presented with a two-week history of dyspnea.
- A pleural biopsy confirmed the diagnosis of alveolar rhabdomyosarcoma.
Findings:
- Fluorescence in situ hybridization detected a positive PAX3-FKHR fusion protein and a negative PAX7-FKHR fusion protein.
- The patient's condition was characterized by a poor prognosis and non-responsiveness to chemotherapy.
Implications:
- This case highlights the importance of considering rare tumor locations in pediatric oncology.
- The specific genetic profile (PAX3-FKHR fusion) may influence treatment strategies and outcomes.
- Further research is needed to understand and improve therapeutic approaches for unreponsive ARMS.